SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Christopher Kenney
Acorda Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Alabama at Birmingham
Birmingham, Alabama, United States
- Banner Sun Health Research Institute
Sun City, Arizona, United States
- Uc San Diego
La Jolla, California, United States
- Parkinson'S Disease & Movement Disorder Center of Boca Raton
Boca Raton, Florida, United States
- Augusta University
Augusta, Georgia, United States
- Northwestern University, Feinberg School of Medicine
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Iowa, Carver College of Medicine
Iowa City, Iowa, United States
- Parkinson'S Disease & Movement Disorder Center, University of Kansas Medical Center
Kansas City, Kansas, United States
- Department of Neurology, University of Maryland Parkinson'S Disease & Movement Disorder Center
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Struthers Parkinson'S Center
Golden Valley, Minnesota, United States
- Atlantic Neuroscience Institute
Summit, New Jersey, United States
- Duke University
Durham, North Carolina, United States
- Wake Forest Baptist Health Sciences
Winston-Salem, North Carolina, United States
- Parkinson'S Disease Movement Disorder Center
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Baylor Univeristy
Houston, Texas, United States
- Houston Methodist Neurological Institute/movement Disorders Clinic
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Dec 2014
- Primary completion
- 3 Oct 2017
- Completion
- 3 Oct 2017
- Last update posted
- 19 Apr 2019
- Registered enrollment
- 82
- Registry id
- NCT02258152
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.